HERNEXEOS Manuals & User Guides

HERNEXEOS 60 mg Zongertinib Tablets INDICATIONS AND USAGE HERNEXEOS is indicated for the treatment of adult patients with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have…

Official prescribing information for HERNEXEOS (zongertinib tablets), a kinase inhibitor for adult patients with unresectable or metastatic non-squamous NSCLC with HER2 (ERBB2) tyrosine kinase domain activating mutations. Includes dosage, warnings,…